Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

(2015) Stephen M. Ansell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

(2014) G. T. Gibney et al.   CLINICAL CANCER RESEARCH

Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer

(2014) S.S. Ramalingam et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma

(2014) B. Liao et al.   NEURO-ONCOLOGY

Ipilimumab: its potential in non-small cell lung cancer

(2011) Pascale Tomasini et al.   Therapeutic Advances in Medical Oncology

Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer

(2009) Amanda C. Peltier et al.   MUSCLE & NERVE